ArticlePakistan journal of medical sciences2026
Comparative analysis of population with positive anti-gliadin antibody and anti-Saccharomyces cerevisiae antibody.
Article in Pakistan journal of medical sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To explore the distribution characteristics of population with positive anti-gliadin antibody (AGA) and anti-Saccharomyces cerevisiae antibody (ASCA), reveal the important value of early detection of AGA and ASCA. Methodology: This is a retrospective comparative analysis. Comparative analysis of AGA and ASCA detected data in Baoding No.1 Central Hospital from February 2021 to February 2024. The rate between groups was compared by χ Results: The ratio of male to female was 1:1.4. The number of male patients with AGA positive was significantly lower than that of females (χ Conclusion: Early detection of AGA and ASCA have definite guiding significance for early diagnosis and differential diagnosis of digestive diseases to reduce misdiagnosis and missed diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.